Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 204

1.

Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of α4β2* nAChRs in Wistar male rats.

Semenova S, Jin X, McClure-Begley TD, Tadman MP, Marks MJ, Markou A.

Pharmacol Biochem Behav. 2018 Aug;171:54-65. doi: 10.1016/j.pbb.2018.06.002. Epub 2018 Jun 14.

PMID:
29908200
2.

Manipulating the Alpha Level Cannot Cure Significance Testing.

Trafimow D, Amrhein V, Areshenkoff CN, Barrera-Causil CJ, Beh EJ, Bilgiç YK, Bono R, Bradley MT, Briggs WM, Cepeda-Freyre HA, Chaigneau SE, Ciocca DR, Correa JC, Cousineau D, de Boer MR, Dhar SS, Dolgov I, Gómez-Benito J, Grendar M, Grice JW, Guerrero-Gimenez ME, Gutiérrez A, Huedo-Medina TB, Jaffe K, Janyan A, Karimnezhad A, Korner-Nievergelt F, Kosugi K, Lachmair M, Ledesma RD, Limongi R, Liuzza MT, Lombardo R, Marks MJ, Meinlschmidt G, Nalborczyk L, Nguyen HT, Ospina R, Perezgonzalez JD, Pfister R, Rahona JJ, Rodríguez-Medina DA, Romão X, Ruiz-Fernández S, Suarez I, Tegethoff M, Tejo M, van de Schoot R, Vankov II, Velasco-Forero S, Wang T, Yamada Y, Zoppino FCM, Marmolejo-Ramos F.

Front Psychol. 2018 May 15;9:699. doi: 10.3389/fpsyg.2018.00699. eCollection 2018. Review.

3.

The interaction of the Chrna5 D398N variant with developmental nicotine exposure.

O'Neill HC, Wageman CR, Sherman SE, Grady SR, Marks MJ, Stitzel JA.

Genes Brain Behav. 2018 Sep;17(7):e12474. doi: 10.1111/gbb.12474. Epub 2018 Apr 17.

PMID:
29573323
4.

Deletion of lynx1 reduces the function of α6* nicotinic receptors.

Parker RL, O'Neill HC, Henley BM, Wageman CR, Drenan RM, Marks MJ, Miwa JM, Grady SR, Lester HA.

PLoS One. 2017 Dec 5;12(12):e0188715. doi: 10.1371/journal.pone.0188715. eCollection 2017.

5.

TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors.

Wall TR, Henderson BJ, Voren G, Wageman CR, Deshpande P, Cohen BN, Grady SR, Marks MJ, Yohannes D, Kenny PJ, Bencherif M, Lester HA.

Front Pharmacol. 2017 Sep 26;8:641. doi: 10.3389/fphar.2017.00641. eCollection 2017.

6.

Reduced α4 subunit expression in α4+- and α4+- /β2+- nicotinic acetylcholine receptors alters α4β2 subtype up-regulation following chronic nicotine treatment.

Moretti M, Fasoli F, Gotti C, Marks MJ.

Br J Pharmacol. 2018 Jun;175(11):1944-1956. doi: 10.1111/bph.13896. Epub 2017 Aug 1.

PMID:
28585241
7.

Density functional theory study of mechanism of epoxy-carboxylic acid curing reaction.

Ly UQ, Pham MP, Marks MJ, Truong TN.

J Comput Chem. 2017 May 30;38(14):1093-1102. doi: 10.1002/jcc.24779.

PMID:
28409848
8.

Gender Role Violations and the Sexual Double Standard.

Zaikman Y, Marks MJ, Young TM, Zeiber JA.

J Homosex. 2016 Dec;63(12):1608-1629. Epub 2016 Mar 1.

PMID:
26930471
9.

Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex.

McClure-Begley TD, Esterlis I, Stone KL, Lam TT, Grady SR, Colangelo CM, Lindstrom JM, Marks MJ, Picciotto MR.

eNeuro. 2016 Aug 16;3(4). pii: ENEURO.0166-16.2016. doi: 10.1523/ENEURO.0166-16.2016. eCollection 2016 Jul-Aug.

10.

Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.

Ondachi PW, Castro AH, Luetje CW, Wageman CR, Marks MJ, Damaj MI, Mascarella SW, Navarro HA, Carroll FI.

ACS Chem Neurosci. 2016 Jul 20;7(7):1004-12. doi: 10.1021/acschemneuro.6b00107. Epub 2016 May 19.

PMID:
27166021
11.

In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of α4β2 nicotinic receptors in cortex and thalamus.

Fasoli F, Moretti M, Zoli M, Pistillo F, Crespi A, Clementi F, Mc Clure-Begley T, Marks MJ, Gotti C.

Neuropharmacology. 2016 Sep;108:324-31. doi: 10.1016/j.neuropharm.2016.04.048. Epub 2016 May 6.

PMID:
27157710
12.

Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner.

Pistillo F, Fasoli F, Moretti M, McClure-Begley T, Zoli M, Marks MJ, Gotti C.

Pharmacol Res. 2016 Jan;103:167-76. doi: 10.1016/j.phrs.2015.11.016. Epub 2015 Nov 26.

PMID:
26631628
13.

Exposure to nicotine increases nicotinic acetylcholine receptor density in the reward pathway and binge ethanol consumption in C57BL/6J adolescent female mice.

Locker AR, Marks MJ, Kamens HM, Klein LC.

Brain Res Bull. 2016 May;123:13-22. doi: 10.1016/j.brainresbull.2015.09.009. Epub 2015 Sep 30.

14.

Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.

Marks MJ, O'Neill HC, Wynalda-Camozzi KM, Ortiz NC, Simmons EE, Short CA, Butt CM, McIntosh JM, Grady SR.

Neuropharmacology. 2015 Dec;99:142-55. doi: 10.1016/j.neuropharm.2015.07.019. Epub 2015 Jul 17.

15.

In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.

Carroll FI, Navarro HA, Mascarella SW, Castro AH, Luetje CW, Wageman CR, Marks MJ, Jackson A, Damaj MI.

ACS Chem Neurosci. 2015 Jun 17;6(6):920-6. doi: 10.1021/acschemneuro.5b00077. Epub 2015 Apr 30.

16.

Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure.

Zambrano CA, Short CA, Salamander RM, Grady SR, Marks MJ.

Pharmacol Res Perspect. 2015 Mar;3(2):e00111. doi: 10.1002/prp2.111.

17.

Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.

Meyers EE, Loetz EC, Marks MJ.

Pharmacol Biochem Behav. 2015 Mar;130:1-8. doi: 10.1016/j.pbb.2014.12.013. Epub 2015 Jan 3.

18.

Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice.

Stoker AK, Marks MJ, Markou A.

Eur J Pharmacol. 2015 Apr 15;753:146-50. doi: 10.1016/j.ejphar.2014.05.062. Epub 2014 Aug 5.

19.

Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.

Sanjakdar SS, Maldoon PP, Marks MJ, Brunzell DH, Maskos U, McIntosh JM, Bowers MS, Damaj MI.

Neuropsychopharmacology. 2015 Jan;40(2):350-60. doi: 10.1038/npp.2014.177. Epub 2014 Jul 18.

20.

Presynaptic GABAB autoreceptor regulation of nicotinic acetylcholine receptor mediated [(3)H]-GABA release from mouse synaptosomes.

McClure-Begley TD, Grady SR, Marks MJ, Collins AC, Stitzel JA.

Biochem Pharmacol. 2014 Sep 1;91(1):87-96. doi: 10.1016/j.bcp.2014.06.010. Epub 2014 Jun 19.

Supplemental Content

Loading ...
Support Center